Comparison of Nurick grading system and modified Japanese Orthopaedic Association scoring system in evaluation of patients with cervical spondylotic myelopathy

比较Nurick分级系统和改良日本骨科协会评分系统在颈椎病脊髓病患者评估中的应用

阅读:1

Abstract

The purpose of this study was to determine the correlation between Nurick grade and modified Japanese Orthopaedic Association (mJOA) scores in the preoperative and postoperative follow-up evaluation of patients with cervical spondylotic myelopathy (CSM). This retrospective study included 93 patients with CSM who underwent central corpectomy (CC) between 1998 and 2008. Preoperative and postoperative Nurick grade and total mJOA (tmJOA) and lower limb mJOA (llmJOA) score of each patient was documented and the correlation between the Nurick grades and the mJOA scores was studied. At presentation and follow-up, correlation between Nurick grade and llmJOA (Spearman's ρ 0.901 and 0.886) was better than with tmJOA (0.846 and 0.862). The Nurick grade recovery rate (NGRR) correlated better with the llmJOARR than with tmJOARR (Spearman's ρ 0.840 and 0.793, respectively). Overall, the correlation of preoperative and follow-up scores and recovery rates was better in patients with moderate myelopathy than in those with mild or severe myelopathy. At follow-up, 78/93 (83.9%) patients had improved in their Nurick grades, whereas 88/93 (94.6%) had improved in their tmJOA scores and 73/93 (78.5%) in their llmJOA scores. Although Nurick grade and llmJOA had good correlation preoperatively, at follow-up evaluation after surgery, there was disagreement in 11.8% (11/93) patients. One of the major reasons for the discrepancy between the Nurick scale and the llmJOA at follow-up evaluation was the ability of patients to regain employment without an improvement in the llmJOA score. As disease-specific scales, both Nurick scale and mJOA score should be utilized in the evaluation of patients with CSM.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。